Patrick Chaltin

2.9k total citations
59 papers, 1.7k citations indexed

About

Patrick Chaltin is a scholar working on Molecular Biology, Infectious Diseases and Virology. According to data from OpenAlex, Patrick Chaltin has authored 59 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 19 papers in Infectious Diseases and 9 papers in Virology. Recurrent topics in Patrick Chaltin's work include Biochemical and Molecular Research (7 papers), HIV/AIDS drug development and treatment (7 papers) and HIV Research and Treatment (7 papers). Patrick Chaltin is often cited by papers focused on Biochemical and Molecular Research (7 papers), HIV/AIDS drug development and treatment (7 papers) and HIV Research and Treatment (7 papers). Patrick Chaltin collaborates with scholars based in Belgium, United Kingdom and Netherlands. Patrick Chaltin's co-authors include Arnaud Marchand, Zeger Debyser, Frauke Christ, Dorothée Bardiot, Belete A. Desimmie, Bruno P.A. Cammue, Karin Thevissen, Damien Marchand, Arnout Voet and Els Meert and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Patrick Chaltin

55 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick Chaltin Belgium 18 910 595 440 278 158 59 1.7k
Arnaud Marchand Belgium 17 825 0.9× 603 1.0× 443 1.0× 277 1.0× 133 0.8× 58 1.5k
Shridhar Bhat United States 21 1.5k 1.7× 333 0.6× 234 0.5× 403 1.4× 148 0.9× 37 2.6k
Antonio Mastino Italy 36 1.1k 1.2× 314 0.5× 239 0.5× 418 1.5× 200 1.3× 120 3.0k
Beatrice Macchi Italy 26 551 0.6× 262 0.4× 226 0.5× 354 1.3× 60 0.4× 101 1.7k
Wolfgang Knecht Sweden 28 1.5k 1.7× 348 0.6× 30 0.1× 111 0.4× 129 0.8× 83 2.1k
Peter Verhasselt Belgium 24 2.2k 2.4× 1.8k 3.0× 49 0.1× 362 1.3× 92 0.6× 48 3.9k
Andrew F. Wilderspin United Kingdom 17 803 0.9× 319 0.5× 262 0.6× 154 0.6× 21 0.1× 26 1.2k
Pia Rauch Germany 16 534 0.6× 506 0.9× 420 1.0× 59 0.2× 71 0.4× 34 1.3k
Noriyuki Habuka Japan 20 1.3k 1.4× 296 0.5× 93 0.2× 378 1.4× 40 0.3× 36 2.5k
Didier Leroy Switzerland 31 1.4k 1.5× 314 0.5× 113 0.3× 291 1.0× 74 0.5× 73 3.7k

Countries citing papers authored by Patrick Chaltin

Since Specialization
Citations

This map shows the geographic impact of Patrick Chaltin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Chaltin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Chaltin more than expected).

Fields of papers citing papers by Patrick Chaltin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Chaltin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Chaltin. The network helps show where Patrick Chaltin may publish in the future.

Co-authorship network of co-authors of Patrick Chaltin

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Chaltin. A scholar is included among the top collaborators of Patrick Chaltin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Chaltin. Patrick Chaltin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chiu, Winston, Niels Cremers, Hugo Klaassen, et al.. (2025). High-throughput split-GFP antiviral screening assay against fusogenic paramyxoviruses. Antiviral Research. 241. 106242–106242.
2.
Wang, Xinyu, Winston Chiu, Hugo Klaassen, et al.. (2023). A Robust Phenotypic High-Throughput Antiviral Assay for the Discovery of Rabies Virus Inhibitors. Viruses. 15(12). 2292–2292. 2 indexed citations
3.
Vanmechelen, Bert, Winston Chiu, Arnaud Marchand, et al.. (2022). Identification of novel Ebola virus inhibitors using biologically contained virus. Antiviral Research. 200. 105294–105294. 6 indexed citations
4.
Eynde, Charlotte Van den, Katharina Held, Katrien De Clercq, et al.. (2022). Loratadine, an antihistaminic drug, suppresses the proliferation of endometrial stromal cells by inhibition of TRPV2. European Journal of Pharmacology. 928. 175086–175086. 11 indexed citations
5.
Hamed, Mohamed Belal, Arnaud Marchand, Jozefien De Geyter, et al.. (2021). Effective Small Molecule Antibacterials from a Novel Anti-Protein Secretion Screen. Microorganisms. 9(3). 592–592. 1 indexed citations
6.
Vanderlinden, Evelien, Arnaud Marchand, Hugo Klaassen, et al.. (2021). A broad influenza virus inhibitor acting via IMP dehydrogenase and in synergism with ribavirin. Antiviral Research. 196. 105208–105208. 6 indexed citations
7.
Bardiot, Dorothée, Michael McNaughton, Suzanne J. F. Kaptein, et al.. (2018). Discovery of Indole Derivatives as Novel and Potent Dengue Virus Inhibitors. Journal of Medicinal Chemistry. 61(18). 8390–8401. 48 indexed citations
8.
Demeulemeester, Jonas, Hugo Klaassen, Arnaud Marchand, et al.. (2018). Inhibitors of the integrase–transportin-SR2 interaction block HIV nuclear import. Retrovirology. 15(1). 5–5. 14 indexed citations
9.
Klaassen, Hugo, Arnaud Marchand, Patrick Chaltin, et al.. (2017). Discovery of a new Mycobacterium tuberculosis thymidylate synthase X inhibitor with a unique inhibition profile. Biochemical Pharmacology. 135. 69–78. 15 indexed citations
10.
Blommaert, Eline, Alex J. O’Neill, Dries De Maeyer, et al.. (2016). Elucidation of the Mode of Action of a New Antibacterial Compound Active against Staphylococcus aureus and Pseudomonas aeruginosa. PLoS ONE. 11(5). e0155139–e0155139. 34 indexed citations
11.
Khan, Niamat, Ali Talebi, Arnaud Marchand, et al.. (2016). Identification of drugs that restore primary cilium expression in cancer cells. Oncotarget. 7(9). 9975–9992. 61 indexed citations
12.
Tijsma, Aloys, Hendrik Jan Thibaut, Stéphane A. Spieser, et al.. (2014). H1PVAT is a novel and potent early-stage inhibitor of poliovirus replication that targets VP1. Antiviral Research. 110. 1–9. 12 indexed citations
13.
Draoui, Nihed, Antony E. Fernandes, Fady Nahra, et al.. (2013). Synthesis and pharmacological evaluation of carboxycoumarins as a new antitumor treatment targeting lactate transport in cancer cells. Bioorganic & Medicinal Chemistry. 21(22). 7107–7117. 51 indexed citations
14.
Helsen, Christine, Arnaud Marchand, Patrick Chaltin, et al.. (2012). Identification and Characterization of MEL-3, a Novel AR Antagonist That Suppresses Prostate Cancer Cell Growth. Molecular Cancer Therapeutics. 11(6). 1257–1268. 13 indexed citations
15.
Pickford, Chris, Frauke Christ, Stephen M. Shaw, et al.. (2011). Pre-clinical evaluation of HIV replication inhibitors that target the HIV-integrase-LEDGF/p75 interaction. Journal of the International AIDS Society. 15. 26–27. 3 indexed citations
16.
Segers, Kenneth, Hugo Klaassen, Anastassios Economou, Patrick Chaltin, & Jozef Anné. (2011). Development of a high-throughput screening assay for the discovery of small-molecule SecA inhibitors. Analytical Biochemistry. 413(2). 90–96. 21 indexed citations
17.
Thevissen, Karin, Arnaud Marchand, Patrick Chaltin, Els Meert, & Bruno P.A. Cammue. (2009). Antifungal Carbazoles. Current Medicinal Chemistry. 16(17). 2205–2211. 103 indexed citations
18.
Chaltin, Patrick, et al.. (2003). Comparison of library screening techniques used in the development of dsDNA ligands. Bioorganic & Medicinal Chemistry Letters. 13(1). 47–50. 7 indexed citations
19.
Chaltin, Patrick, et al.. (2003). New dsDNA‐Binding Hybrid Molecules Combining an Unnatural Peptide and an Intercalating Moiety. Helvetica Chimica Acta. 86(3). 533–547. 3 indexed citations
20.
Zhang, Zhen‐Yu, Patrick Chaltin, Arthur Van Aerschot, et al.. (2002). New dsDNA binding unnatural oligopeptides with pyrimidine selectivity. Bioorganic & Medicinal Chemistry. 10(11). 3401–3413. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arnaud Marchand Breakdown of academic impact, for papers by Shridhar Bhat Breakdown of academic impact, for papers by Antonio Mastino Breakdown of academic impact, for papers by Beatrice Macchi Breakdown of academic impact, for papers by Wolfgang Knecht Breakdown of academic impact, for papers by Peter Verhasselt Breakdown of academic impact, for papers by Andrew F. Wilderspin Breakdown of academic impact, for papers by Pia Rauch Breakdown of academic impact, for papers by Noriyuki Habuka Breakdown of academic impact, for papers by Didier Leroy
Rankless by CCL
2026